SANTEN PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,512 JPY | +1.41% |
|
+4.13% | +7.65% |
Chart calendar Santen Pharmaceutical Co., Ltd.
c586e7312ef.6qypufEC_1Cy5K18Fu9fpA4WWXkQeLxJ9Y761yyZCjg.puLk2pdqzWnohfRMXoA9wWt_DDBPGfUAx7-JrXrBb1Ob3eL4p0yLOP2h2g~94e083bcc624f051963bd4326fb4721e
Upcoming events on Santen Pharmaceutical Co., Ltd.
Past events on Santen Pharmaceutical Co., Ltd.
| 2024-03-27 | Final dividend |
| 2024-02-07 | Q3 2023 Earnings Release |
| 2023-11-07 | Q2 2023 Earnings Call |
| 2023-11-06 | Q2 2023 Earnings Release |
| 2023-09-27 | Ex-dividend day for dividende intermédiaire |
| 2023-08-02 | Q1 2023 Earnings Call |
| 2023-08-02 | Q1 2023 Earnings Release |
| 2023-06-26 | Annual General Meeting |
| 2023-05-10 | Q4 2022 Earnings Call |
| 2023-05-10 | Q4 2022 Earnings Release |
| 2023-04-12 | Analyst Meeting - Medium Term Management Plan 2023-2025 |
| 2023-03-29 | Ex-dividend day for final dividend |
| 2023-02-06 | Q3 2022 Earnings Call |
| 2023-02-06 | Q3 2022 Earnings Release |
| 2022-11-08 | Interim 2022 Earnings Call |
| 2022-11-07 | Interim 2022 Earnings Release |
| 2022-09-28 | Ex-dividend day for dividende intermédiaire |
| 2022-08-03 | Q1 2022 Earnings Call |
| 2022-08-03 | Q1 2022 Earnings Release |
| 2022-06-23 | Annual General Meeting |
Past dividends on Santen Pharmaceutical Co., Ltd.
| 2024-03-27 | Final Payment 17 JPY |
| 2023-09-27 | Interim Payment 16 JPY |
| 2023-03-29 | Final Payment 16 JPY |
| 2022-09-28 | Interim Payment 16 JPY |
| 2022-03-29 | Final Payment 16 JPY |
| 2021-09-28 | Interim Payment 16 JPY |
| 2021-03-29 | Final Payment 14 JPY |
| 2020-09-28 | Interim Payment 14 JPY |
| 2020-03-29 | Final Payment 14 JPY |
| 2019-09-26 | Interim Payment 13 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 234 026 235 088 -0.45% | 241 555 245 590 -1.64% | 249 605 247 367 0.9% | 266 257 263 731 0.96% | 279 037 273 444 2.05% | 301 449 |
|
EBITDA Million JPY | Released Forecast Spread | 56 067 55 242 1.49% | 50 108 50 493 -0.76% | 29 685 44 027 -32.57% | 52 941 56 368 -6.08% | 14 159 32 053 -55.83% | 63 976 |
|
EBIT Million JPY | Released Forecast Spread | 45 098 43 952 2.61% | 33 535 37 882 -11.47% | 12 917 22 943 -43.7% | 35 886 39 523 -9.2% | -3 090 -4 983 37.99% | 44 636 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 43 117 42 989 0.3% | 32 091 34 188 -6.13% | 12 418 22 200 -44.06% | 35 616 39 086 -8.88% | -5 799 -7 540 23.09% | 41 245 |
|
Net income Million JPY | Released Forecast Spread | 31 954 31 939 0.05% | 23 618 25 173 -6.18% | 6 830 14 029 -51.31% | 27 218 29 030 -6.24% | -14 948 -15 825 5.54% | 31 721 |
|
EPS JPY | Released Forecast Spread | 78,7 79,1 -0.55% | 59,2 66,0 -10.42% | 17,1 34,9 -51% | 68,1 72,7 -6.33% | -38,6 -42,4 8.96% | 90,9 |
| Announcement Date | 09/05/19 | 08/05/20 | 11/05/21 | 10/05/22 | 11/05/23 | - |
Quarterly results
| Fiscal Period | Marzo | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 S1 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 118 775 116 000 2.39% | 118 905 116 600 1.98% | 128 759 118 850 8.34% | 67 042 66 461 0.87% | 70 456 68 699 2.56% | 65 533 61 050 7.34% | 63 382 63 188 0.31% | 128 915 131 800 -2.19% | 70 871 69 762 1.59% | 79 251 76 787 3.21% | 72 389 67 033 7.99% | 73 417 66 056 11.14% | 145 806 140 000 4.15% | 77 027 73 700 4.51% | 78 097 | 72 500 | 146 000 | 140 500 |
|
EBITDA Million JPY | Released Forecast Spread | 15 743 13 700 14.91% | |||||||||||||||||
|
EBIT Million JPY | Released Forecast Spread | 19 000 13 100 45.04% | 18 686 17 100 9.27% | 18 805 21 500 -12.53% | 7 575 10 260 -26.17% | 9 506 13 120 -27.55% | 8 333 6 750 23.45% | -27 354 6 784 -503.24% | -19 021 17 900 -206.26% | 8 874 7 599 16.78% | 7 057 5 993 17.76% | 12 750 7 400 72.3% | 12 349 4 775 158.62% | 25 099 16 600 51.2% | 11 058 9 000 22.87% | 6 973 | 12 200 | 25 800 | 25 400 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 18 400 13 000 41.54% | 18 353 17 000 7.96% | 18 393 19 000 -3.19% | 7 280 11 796 -38.28% | 9 074 5 900 53.8% | -28 177 8 565 -428.98% | -19 103 17 900 -206.72% | 7 510 8 686 -13.53% | 5 794 3 967 46.05% | 12 868 7 950 61.86% | 24 075 15 300 57.35% | 9 484 7 500 26.45% | 11 900 | 24 700 | 24 300 | |||
|
Net income Million JPY | Released Forecast Spread | 13 100 13 000 0.77% | 13 813 12 200 13.22% | 14 307 14 145 1.15% | 5 042 8 396 -39.95% | 6 663 4 400 51.43% | -28 704 6 065 -573.27% | -22 041 13 400 -264.49% | 5 977 6 281 -4.83% | 1 116 967 15.41% | 10 414 5 975 74.29% | 8 866 2 900 205.72% | 19 280 12 200 58.03% | 7 333 5 700 28.65% | 6 347 | 9 100 | 19 100 | 18 700 | |
|
EPS JPY | Released Forecast Spread | 32,9 32,6 1.04% | 34,6 29,7 16.43% | 35,8 35,4 1.1% | 12,6 14,8 -14.58% | 19,7 19,6 0.36% | 16,8 12,0 39.68% | -72,8 9,66 -854.04% | -56,1 34,6 -261.99% | 14,9 11,9 25.22% | 2,53 2,33 8.58% | 27,9 17,6 59.05% | 24,1 13,2 82.94% | 52,1 30,5 70.69% | 20,2 16,8 20.53% | 12,5 | 25,4 | 47,8 | 46,8 |
| Announcement Date | 06/11/19 | 06/11/20 | 08/11/21 | 10/02/22 | 10/05/22 | 04/08/22 | 08/11/22 | 08/11/22 | 07/02/23 | 11/05/23 | 03/08/23 | 07/11/23 | 07/11/23 | 08/02/24 | - | - | - | - |
More events
Past sector events for Santen Pharmaceutical Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4536 Stock
- Calendar Santen Pharmaceutical Co., Ltd.
